HRI, SANPUD, VOCAL Kenya, Rumah Cemara and EHRA urged the Global Fund to maintain its commitment to harm reduction funding (including by promoting domestic investment) as well as community-led programming.
Magnolini et al. show drug checking offers valuable information and accountability in the context of a dynamic and uncertain supply of unregulated substances, whilst highlighting policy barriers hindering accessibility.
The HIV Legal Network argue for a human rights approach, focusing on evidence-based and culturally sensitive interventions that embrace Indigenous ways of knowing and doing.
Russoniello et al. examine the provisions, early impacts, successes, and challenges of Measure 110, a ballot initiative in Oregon that decriminalized possession of small quantities of all drugs and allocated vital funding to health services for people who use drugs.
Brandt provides insight on how the pharmacy profession can play a role in legal reform, regulatory policy creation, and pharmacy operations to broaden access to psychedelics while mitigating harm, using Canada as a case study.
INPUD, WHO and UNODC update WHO's Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care in relation to people who inject drugs.
C-EHRN outlines the importance of cooperation between
civil society organisations and state agencies, accompanied by adequate funding and a clear mandate for service providers in the face of a challenging and constantly changing harm reduction landscape.
Kammersgaard highlights how existing rationalities and practices associated with prohibition often remain intact in decriminalisation proposals, despite a push towards health and human rights.
CGHE and INHSU Prisons note that persons who are incarcerated experience the highest burdens of HCV globally and should therefore have the right to access HCV services, but they too often face systematic discrimination.
The EMCDDA present their findings of the largest European project to date in the emerging science of wastewater analysis, conducted in over 100 European cities and towns to explore the drug-taking habits of people who live in them.
